Welcome to My Every Daily Blogs, your trusted source for in-depth educational insights on advanced research compounds. Today, we explore three next-generation nootropics: Coluracetam, RGPU-95, and Unifiram Powder.*
The field of cognitive neuroscience is advancing rapidly, with researchers continually seeking novel compounds to study memory consolidation, neuroplasticity, and cholinergic signaling. Among the most promising classes of research chemicals are the racetam family and its structural analogues. Coluracetam, RGPU-95, and Unifiram represent three distinct mechanisms of action, offering researchers unique tools for in vitro and in vivo studies.
In this comprehensive guide, we will examine the pharmacological profiles, mechanism of action, key research findings, and safety data for each compound. Please note: The following content is strictly for educational and research purposes. These compounds are not approved for human consumption, and this information is intended solely for use by licensed professionals in controlled laboratory settings.
For verified analytical standards and high-purity research materials, advanced researchers are encouraged to collaborate with trusted suppliers like Research Trade Lab Ltd.
Table of Contents
- Coluracetam: The High-Affinity Choline Uptake Enhancer
- RGPU-95: The Potent Piracetam Analogue
- Unifiram: The AMPAkine with Rapid Onset
- Comparative Analysis: Mechanisms & Potency
- Quality & Purity for Researchers
- Frequently Asked Questions
- Conclusion & Future Directions
Section 1: Coluracetam (BCI-540) โ The High-Affinity Choline Uptake Enhancer
What is Coluracetam?
Coluracetam (developmental code BCI-540) is a synthetic nootropic compound belonging to the racetam family. Unlike classic racetams such as Piracetam or Aniracetam, Coluracetam features a unique fused tricyclic structure that confers distinct pharmacological properties.
Mechanism of Action
The primary mechanism of Coluracetam is High-Affinity Choline Uptake (HACU) enhancement. Choline is the rate-limiting precursor for acetylcholine synthesis. By increasing HACU, Coluracetam promotes greater acetylcholine production in cholinergic neurons, particularly in the hippocampus and basal forebrain.
Key Mechanistic Data:
- Target:ย High-affinity choline transporter (CHT1)
- Effect:ย Increases choline transport capacity without altering choline affinity
- Resulting Action:ย Enhanced acetylcholine synthesis and release
Unlike acetylcholinesterase inhibitors (which prevent breakdown of existing acetylcholine), Coluracetam works upstream by ensuring adequate precursor supply. This mechanism is particularly relevant for researchers studying age-related cognitive decline and cholinergic hypofunction.
Additional Mechanisms
Research suggests Coluracetam may also:
- Modulate AMPA receptorsย โ Indirect positive modulation contributing to its cognitive effects
- Exhibit neuroprotective propertiesย โ Reduces glutamate-induced excitotoxicity in neuronal cell cultures
- Influence BDNF expressionย โ Brain-derived neurotrophic factor upregulation observed in rodent models
Key Research Findings
Memory Enhancement Studies
In rodent models (Morris water maze and passive avoidance tests):
- Scopolamine-induced amnesia:ย Coluracetam (0.1โ1.0 mg/kg, oral) significantly reversed memory deficits
- Working memory:ย Improved performance in delayed matching-to-sample tasks
- Long-term potentiation (LTP):ย Enhanced LTP in hippocampal slices, a cellular correlate of memory formation
Safety & Toxicology Data
- LD50 (rat, oral):ย >2000 mg/kg (low acute toxicity)
- hERG inhibition:ย Negligible at therapeutic concentrations (no cardiotoxicity risk)
- CYP450 interactions:ย Minimal inhibition of major CYP isozymes
Pharmacokinetics (Rodent Data)
| Parameter | Value |
|---|---|
| Oral bioavailability | ~40-50% |
| Tmax (peak plasma) | 1-2 hours |
| Half-life (tยฝ) | 2-3 hours |
| Brain penetration | High (crosses BBB readily) |
Research Applications
- Alzheimer’s disease models:ย Studying cholinergic restoration strategies
- Traumatic brain injury (TBI):ย Investigating neurorepair mechanisms
- Schizophrenia:ย Cognitive deficit remediation studies (Coluracetam was in Phase II trials for this indication)
For researchers conducting HACU or cholinergic signaling studies, Buy Coluracetam Online as a certified reference material from Research Trade Lab Ltd.
Section 2: RGPU-95 (Phenylpiracetam Hydrazide) โ The Potent Piracetam Analogue
Understanding RGPU-95
RGPU-95 (Phenylpiracetam hydrazide) is a novel racetam derivative developed by Russian researchers as a structural analogue of Phenylpiracetam (Phenotropil). The hydrazide modification significantly alters its pharmacokinetic and pharmacodynamic profile.
Mechanism of Action
RGPU-95 exhibits a multimodal mechanism distinct from other racetams:
- AMPA Receptor Positive Modulationย โ Primary mechanism; enhances glutamate signaling at AMPA receptors
- Nicotinic Acetylcholine Receptor (nAChR) Activationย โ Specifically ฮฑ4ฮฒ2 and ฮฑ7 subtypes
- Dopamine Transporter (DAT) Inhibitionย โ Weak-to-moderate affinity, contributing to stimulant effects
Potency Comparison: RGPU-95 vs. Other Racetams
| Compound | Relative Potency (vs Piracetam = 1x) | Primary Mechanism |
|---|---|---|
| Piracetam | 1x | AMPA modulation (weak) |
| Aniracetam | 5-10x | AMPA + 5-HT2A |
| Pramiracetam | 10-15x | Cholinergic |
| Phenylpiracetam | 30-60x | AMPA + DAT inhibition |
| RGPU-95 | 100-200x | AMPA + nAChR + DAT |
Key Research Findings
Cognitive Enhancement Data
In validated rodent models (rat passive avoidance and Morris water maze):
- Effective dose range:ย 0.5โ5 mg/kg (oral)
- Onset of action:ย 30-60 minutes
- Duration of effect:ย 6-8 hours (significantly longer than Phenylpiracetam’s 3-4 hours)
Physical Performance Studies
RGPU-95 retained the physical endurance-enhancing properties of Phenylpiracetam:
- Forced swim test:ย Increased swim time by 40% (2 mg/kg dose)
- Rotarod performance:ย Improved motor coordination and resistance to fatigue
Neuroprotective Properties
- Hypoxia resistance:ย RGPU-95 (5 mg/kg) increased survival time in hypoxic conditions by 60% in rodent models
- Ischemia protection:ย Reduced infarct volume in middle cerebral artery occlusion (MCAO) models
Safety Profile
- LD50 (rat, oral):ย Approx. 800 mg/kg (moderate toxicity)
- Stimulant effects:ย Notable increase in locomotor activity at doses >5 mg/kg
- Tolerance:ย Less tolerance development compared to classical psychostimulants
Research Applications
- Cognitive fatigue studies:ย Investigating the interface between physical stamina and mental performance
- Neuroprotection in hypoxic/ischemic injury:ย Models of stroke and traumatic brain injury
- Attention deficit disorders:ย Animal models of inattention and impulsivity
*Access high-purity RGPU-95 for your AMPA receptor or neuroprotection studies.ย Buy RGPU-95 Onlineย exclusively fromย Research Trade Lab Ltd.
Section 3: Unifiram (DM-232) โ The AMPAkine with Rapid Onset
What is Unifiram?
Unifiram (developmental code DM-232) is a synthetic nootropic compound structurally unrelated to racetams. It belongs to the pyrazolo-pyridine class and is often categorized as an AMPArkine โ a compound that positively modulates AMPA receptors with high potency.
Unique Chemical Structure
Unlike the pyrrolidone ring of racetams, Unifiram features a pyrazolo[1,5-a]pyrimidine core. This unique structure confers:
- Ultra-high potencyย (active in sub-milligram doses)
- Rapid brain penetrationย (Tmax in brain < 15 minutes)
- Distinct binding siteย on AMPA receptors (non-competitive with traditional AMPArkines)
Mechanism of Action
Unifiram’s primary mechanism is positive allosteric modulation of AMPA receptors:
- Target:ย GluA2-containing AMPA receptors
- Binding site:ย Distinct from cyclothiazide or aniracetam sites
- Effect:ย Slows deactivation kinetics, increasing peak current and charge transfer
Secondary mechanisms include:
- Weak inhibition of GABA-A receptors (at high concentrations)
- Modulation of kainate receptors (minor contribution)
Potency Comparison: Unifiram vs. Other AMPArkines
| Compound | Effective Dose (rodent, oral) | Potency vs Piracetam | Onset |
|---|---|---|---|
| Piracetam | 300-1000 mg/kg | 1x | Slow |
| Aniracetam | 10-50 mg/kg | 10-50x | Moderate |
| CX-516 (Ampakine) | 10-40 mg/kg | 20-80x | Fast |
| Unifiram | 0.5-2 mg/kg | 500-2000x | Very Fast |
| Sunifiram (analogue) | 0.3-1 mg/kg | 1000-3000x | Very Fast |
Key Research Findings
Memory Enhancement Data
In validated cognitive paradigms:
- Passive avoidance (rat):ย Unifiram (0.5 mg/kg, oral) improved retention latency by 300% compared to control
- Morris water maze:ย Reduced escape latency to platform by 65% after 5 days of treatment (1 mg/kg)
- Novel object recognition:ย Improved discrimination index at 30-minute and 24-hour retention intervals
AMPA Receptor Binding Data (In Vitro)
| Assay | Unifiram | Aniracetam | CX-516 |
|---|---|---|---|
| EC50 (AMPA potentiation) | 0.8 ฮผM | 50 ฮผM | 12 ฮผM |
| Max potentiation (%) | 350% | 200% | 250% |
| Deactivation slowing (ฯ) | 8x | 3x | 4x |
Safety & Toxicology
- LD50 (rat, oral):ย >500 mg/kg (low acute toxicity)
- Seizure threshold:ย Slight reduction at high doses (>5 mg/kg) โ caution for epilepsy research
- Off-target effects:ย Minimal affinity for 5-HT, dopamine, or adrenergic receptors
Pharmacokinetics (Rodent Data)
| Parameter | Value |
|---|---|
| Oral bioavailability | ~60% |
| Tmax (brain) | 15 minutes |
| Half-life (tยฝ) | 1.5 hours |
| Brain/plasma ratio | 8:1 (extensive brain accumulation) |
Research Applications
- AMPA receptor pharmacology:ย Structure-activity relationship studies
- Synaptic plasticity:ย LTP and learning mechanisms
- Cognitive disorders:ย Models of memory impairment (Alzheimer’s, age-related decline)
- Rapid-onset interventions:ย Situations requiring fast cognitive enhancement
For ultra-high potency AMPA receptor studies, Buy Unifiram Powder Online from a trusted supplier like Research Trade Lab Ltd.
Section 4: Comparative Analysis โ Coluracetam vs. RGPU-95 vs. Unifiram
Mechanism Summary Table
| Feature | Coluracetam | RGPU-95 | Unifiram |
|---|---|---|---|
| Primary Mechanism | HACU enhancement | AMPA + nAChR + DAT | AMPA PAM |
| Secondary Mechanism | AMPA modulation (weak) | Cholinergic activation | GABA-A inhibition (weak) |
| Primary Target | CHT1 transporter | AMPA/GluA2 | AMPA/GluA2 |
| Potency (vs Piracetam) | ~3-5x | ~100-200x | ~500-2000x |
| Effective Dose (rat) | 0.5-5 mg/kg | 0.5-5 mg/kg | 0.5-2 mg/kg |
| Duration of Action | 2-4 hours | 6-8 hours | 1-3 hours |
| Onset of Action | 1-2 hours | 30-60 min | 15-30 min |
| Blood-Brain Barrier | High penetration | High penetration | Very high |
Research Application Recommendations
| Research Focus | Recommended Compound |
|---|---|
| Cholinergic deficiency models (Alzheimer’s) | Coluracetam |
| Traumatic brain injury / hypoxia | RGPU-95 |
| AMPA receptor structure-activity | Unifiram |
| Physical + cognitive fatigue | RGPU-95 |
| Rapid-onset memory enhancement | Unifiram |
| Long-duration studies (multiple hours) | RGPU-95 |
| Synergistic combination research | Coluracetam + Unifiram (cholinergic + glutamatergic) |
Section 5: Quality & Purity for Researchers โ Buyer’s Guide
For researchers conducting reproducible experiments, compound purity is non-negotiable. Impurities can:
- Confound receptor binding data
- Produce false positives/negatives in cell-based assays
- Alter pharmacokinetic parameters
Critical Quality Metrics
| Parameter | Acceptable Range for Research | Ideal Standard |
|---|---|---|
| Purity (HPLC) | โฅ98% | โฅ99.5% |
| Single largest impurity | <0.5% | <0.1% |
| Residual solvents | <5000 ppm | <1000 ppm |
| Heavy metals | <20 ppm | <5 ppm |
| Water content (Karl Fischer) | <2% | <0.5% |
Analytical Documentation Required
When procuring research compounds, always request:
- Certificate of Analysis (COA)ย โ HPLC chromatogram showing purity
- Mass Spectrometry (MS)ย โ Confirmation of molecular weight
- NMR Spectroscopyย โ Structural verification (ยนH and ยนยณC)
- Residual Solvent Analysisย โ GC-MS data
- Heavy Metal Screenย โ ICP-MS data
Storage Recommendations
| Compound | Storage Condition | Shelf Life |
|---|---|---|
| Coluracetam | Cool, dry, dark (15-25ยฐC) | 24 months |
| RGPU-95 | Cool, dry, desiccated | 18 months |
| Unifiram | Amber vial, refrigeration (2-8ยฐC) | 12 months |
My Every Daily Blogs recommendsย Research Trade Lab Ltdย for all three compounds.
Section 6: Frequently Asked Questions
Q1: Are Coluracetam, RGPU-95, and Unifiram legal to purchase for research?
A: Legal status varies by country. In many jurisdictions, these compounds are unscheduled and permitted for laboratory research (not human consumption). However, some countries (e.g., China’s 2021 ban on racetam analogues) have restricted them. Always verify local regulations before ordering.
Q2: How do these compounds differ from Piracetam?
A: All three are significantly more potent. Piracetam is active at 300-1000 mg/kg in rodents, while these compounds are active at 0.5-5 mg/kg โ a 100- to 2000-fold increase in potency. Mechanisms also differ: Coluracetam targets choline uptake, RGPU-95 hits multiple receptors, and Unifiram is a pure AMPAkine.
Q3: Can these compounds be used in combination for research?
A: Yes. Researchers have studied Coluracetam (cholinergic enhancement) plus Unifiram (glutamatergic enhancement) as a synergistic combination targeting both major memory systems. However, proper dosing and controls are essential.
Q4: What solvents are recommended for in vitro studies?
A:
- DMSO:ย For stock solutions (10-50 mM) โ dilute to final concentration <0.1% DMSO in cell culture
- Ethanol:ย 10-25 mg/mL solubility โ suitable for behavioral studies
- Saline + PEG-400:ย For intravenous administration
Q5: How should Unifiram powder be handled due to its high potency?
A: Unifiram is active in sub-milligram doses. Always use calibrated microbalances and perform serial dilutions. Use volumetric preparation for accuracy: dissolve known mass in DMSO, then dilute with buffer or saline.
Section 7: Conclusion & Future Research Directions
Coluracetam, RGPU-95, and Unifiram represent the cutting edge of nootropic research. Each compound offers a distinct mechanism:
- Coluracetamย stands alone as a high-affinity choline uptake enhancer โ a unique tool for studying cholinergic neurotransmission.
- RGPU-95ย provides a longer-duration, multi-target alternative to Phenylpiracetam for fatigue and neuroprotection research.
- Unifiramย is among the most potent AMPAkines available, enabling researchers to study AMPA receptor dynamics at nanomolar concentrations.
Future research directions include:
- Combination therapiesย โ Cholinergic + glutamatergic co-administration in neurodegeneration models
- Isomer-specific activityย โ Investigating stereoisomer contributions
- Chronic dosing protocolsย โ Understanding tolerance and receptor regulation
- Metabolic identificationย โ LC-MS/MS metabolite profiling
Disclaimer: The content on My Every Daily Blogs is for informational purposes only. We do not condone the misuse of research chemicals. Our content is intended for licensed researchers and industrial professionals only.
Source: My Every Daily Blogs
Partner Link: Research Trade Lab Ltd
